Home / Market News / $GNDX
fiscal.ai Corporate Catalyst Impact 75/100 ● negative

Analysts Adjust Estimates and Price Targets for GeneDx Holdings Following Quarterly Results

Nov 13, 2026, 2:04 PM UTC · Primary ticker $GNDX

GeneDx Holdings' recent quarterly report led analysts to downgrade revenue estimates and increase loss-per-share projections for the coming year, despite revenue aligning with expectations. The larger-than-anticipated loss per share and subsequent reduction in price targets indicate increased pessimism regarding the company's near-term intrinsic value, potentially impacting investor sentiment negatively.

GeneDx Holdings reported quarterly revenue that met analyst expectations, but its loss per share exceeded predictions by 7.3%. This larger-than-expected loss has prompted analysts to downgrade future revenue estimates and increase loss-per-share projections, leading to reduced price targets for the stock. This indicates a more pessimistic outlook on the company's near-term financial performance and intrinsic value, which could pressure the stock in the short term. However, the filing also notes that GeneDx is still projected to achieve 21% annualized revenue growth through 2027, outpacing the broader industry, suggesting potential long-term opportunities if the company can manage its losses effectively.

$GNDX negative Analyst downgrades and increased loss projections
Source: fiscal.ai
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.